The FDA has approved a novel synthetic scaffold that would allow stem cells to regrow bone more efficiently. The proprietary technology, Osteo-P [from Molecular Matrix Inc.], replaces the use of bone grafts and utilizes the patient’s own stem cells to regrow bone following trauma or injury. The Osteo-P, a scaffold made of carbohydrate [sugar] polymer, is an improved alternative to current bone grafting procedures in that it enables the body’s own stem cells to regenerate bone in aggregate, and it is resorbed by the body as it is replaced by the newly formed bone.
The founder of Molecular Matrix and an assistant adjunct professor of Human Anatomy and Cell Biology at UC Davis, Charles Lee comments, “building up stem cells is not easy. It requires a scaffold—a matrix or structure—to help support the cells to grow into an organoid.” This makes this new technology an ideal method to improve stem cell efficacy in bone regeneration and could help millions across the world suffering from a variety of bone deficits.
The innovative research being carried out at UC Davis demonstrates the integral role stem cells are playing in cutting edge medical care options. By banking their own valuable stem cells, families can ensure that they will have access to these emerging therapies in the near future. To learn more about banking stem cells, please visit StemSave or call 877-783- 6728 (877-StemSave) today
The Future of Regenerative Medicine is Now™
To view the full article, click here.